SEC
SlamSEC
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)
4
PeriodMar 4, 2026
FiledMar 6, 2026
0001735276-26-000060
Documents
View on EDGAR ↗

No inline preview available for this filing.

Select a document from the panel, or view it directly on EDGAR.

View filing on EDGAR ↗